Skip Navigation
  Print Page

Buonanno Lab: Section on Molecular Neurobiology

Skip sharing on social media links
Share this:
Skip Internal Navigation

What We Do

Neuregulins and Neuronal Plasticity: Their Possible Relevance in Schizophrenia Polymorphisms in the Neuregulin-1 (NRG-1) and ErbB-4 receptor genes have been genetically associated in numerous cohort and family studies with schizophrenia, a prevalent developmental psychiatric disorder that afflicts over 1% of the population worldwide. Importantly, a NRG-1 polymorphism is associated with poor cognitive function and increased risk of psychosis, two characteristics associated with schizophrenia. Moreover, biochemical analyses of synaptic proteins in membranes isolated from postmortem brains of afflicted individuals indicate that the NRG-ErbB signaling pathway is altered in schizophrenia.

Neuregulins are a family of trophic and differentiation factors that signal via the ErbB receptor tyrosine kinase family; ErbB-4 is the major receptor expressed in neurons. We, and others, have shown that NRG/ErbB signaling during development and in the adult regulates the expression of neurotransmitter receptors for glutamate, GABA and acetylcholine), myelination, and neuronal migration. Our recent work indicates the NRG signaling regulates plasticity at glutamatergic synapses, an intriguing finding given the importance of these functions for memory and cognition, and because of the proposed deficits in glutamate neurotransmission associated with schizophrenia. Interestingly, the activation of ErbB-4 receptors in the hippocampus reverses long-term potentiation at glutamatergic synapses by selectively promoting the internalization of GluR1-containing AMPA receptors. Interestingly, genetically altered mice that express lower levels of NRG-1 and ErbB-4 exhibit a series of alte! red behaviors that are similar to other animal models of schizophrenia, and treatment of these mutants with antipsychotics ameliorates their symptoms. The continued focus of our laboratory will be to use animal models to elucidate how imbalances in the NRG/ErbB signaling pathway regulate neuronal function and behavior, with the ultimate goal of understanding how this pathway can contribute to normal brain function and alterations associated psychiatric disorders.​​

Last Updated Date: 11/30/2012
Last Reviewed Date: 11/30/2012

Contact Information

Name: Dr Andres L Buonanno
Senior Investigator
Section on Molecular Neurobiology
Phone: 301-496-0170
Fax: 301-480-2707
Email: buonanno@mail.nih.gov

Staff Directory
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology